Chi-Med links with Cambridge University for angiogenesis research
This article was originally published in Scrip
Executive Summary
Hutchison China MediTech (Chi-Med) has entered into a three-year basic research collaboration with the University of Cambridge in the UK to investigate the angiogenic effects of a number of proprietary and non-proprietary substances derived from Chinese medicinal plants.